{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:25:35Z","timestamp":1776979535723,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12026-019-9068-1","type":"journal-article","created":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T06:02:30Z","timestamp":1548050550000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Tryptophan-kynurenine profile in pediatric autoimmune hepatitis"],"prefix":"10.1007","volume":"67","author":[{"given":"Simon D.","family":"Lytton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Osiecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ma\u0142gorzataWo\u017aniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u017cena","family":"Cukrowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldona","family":"Wierzbicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Goliszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Socha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Janczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek","family":"Dayanakli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Abendroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Kramp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Scheper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Bentow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimietrios","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Woynarowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,21]]},"reference":[{"key":"9068_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","volume":"66","author":"DG Doherty","year":"2018","unstructured":"Doherty DG. Immunity, tolerance and autoimmunity in the liver: a comprehensive review. J Autoimmun. 2018;66:60\u201375.","journal-title":"J Autoimmun"},{"key":"9068_CR2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3389\/fimmu.2017.01889","volume":"8","author":"RE Wawman","year":"2018","unstructured":"Wawman RE, Bartlett H, Oo YH. Regulatory T cell metabolism in the hepatic microenvironment. Front Immunol. 2018;8:1889. \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.01889\n                    \n                  .","journal-title":"Front Immunol"},{"key":"9068_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/cei.12956","volume":"189","author":"CR Grant","year":"2017","unstructured":"Grant CR, Holder BS, Liberal R, Heneghan MA, Ma Y, Mieli-Vergani G, et al. Immunosuppressive drugs affect interferon (IFN)-\u03b3 and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis. Clin Exp Immunol. 2017;189:71\u201382.","journal-title":"Clin Exp Immunol"},{"key":"9068_CR4","first-page":"682","volume":"15","author":"BE Behairy","year":"2016","unstructured":"Behairy BE, El-Araby HA, Abd El Kader HH, et al. Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis. Ann Hepatol. 2016;15:682\u201390.","journal-title":"Ann Hepatol"},{"key":"9068_CR5","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1007\/s10620-015-3687-8","volume":"60","author":"Y Xue","year":"2015","unstructured":"Xue Y, Michalopoulos G. Tregs: a therapeutic target for the treatment of portal fibrosis? Dig Dis Sci. 2015;60:1878\u201380.","journal-title":"Dig Dis Sci"},{"key":"9068_CR6","doi-asserted-by":"publisher","first-page":"929e938","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FP. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929e938.","journal-title":"J Hepatol"},{"key":"9068_CR7","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","volume":"51","author":"MP Manns","year":"2010","unstructured":"Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51:2193\u2013213.","journal-title":"Hepatology"},{"key":"9068_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AI, Pares A, Dalekos GN, et al. International autoimmune hepatitis group simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u201376.","journal-title":"Hepatology"},{"key":"9068_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","author":"EASL Clinical Practice Guidelines","year":"2015","unstructured":"EASL Clinical Practice Guidelines. Autoimmune hepatitis European association for the study of the liver. J Hepatol. 2015;63:971\u20131004.","journal-title":"J Hepatol"},{"issue":"2","key":"9068_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","volume":"66","author":"G Mieli-Vergani","year":"2017","unstructured":"Mieli-Vergani G, Vergani D, Baumann U, Czubkowski P, Debray D, Dezsofi A, et al. Diagnosis and management of paediatric autoimmune liver disease: ESPGHAN hepatology committee position statement. J Pediatr Gastroenterol Nutr. 2017;66(2):345\u201360.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9068_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","volume":"46","author":"A Floreani","year":"2013","unstructured":"Floreani A, Liberal R, Vergani D, Mieli-Vergani G. Autoimmune hepatitis: contrast and comparison in children and adults-a comprehensive review. J Autoimmun. 2013;46:7\u201316.","journal-title":"J Autoimmun"},{"key":"9068_CR12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.autrev.2016.03.001","volume":"15","author":"R Healey","year":"2016","unstructured":"Healey R, Corless L, Gordin P, Holding S. Do anti-smooth muscle antibodies predict development of autoimmune hepatitis in patients with normal liver function? A retrospective cohort review. Autoimmun Rev. 2016;15:668\u201372.","journal-title":"Autoimmun Rev"},{"key":"9068_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.14218\/JCTH.2014.00032","volume":"3","author":"R Liberal","year":"2015","unstructured":"Liberal R, Vergani D, Mieli-Vergani G. Update on autoimmune hepatitis. J Clin Trans Hepatol. 2015;3:42\u201352.","journal-title":"J Clin Trans Hepatol"},{"issue":"5","key":"9068_CR14","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/jcla.21907","volume":"30","author":"M Woynarowski","year":"2016","unstructured":"Woynarowski M, Wo\u017aniak M, Cukrowska B, Cukrowska B, Wierzbicka A, Lytton SD. Autoantibody profile of adult patients with childhood onset type 2 autoimmune hepatitis. J Clin Lab Anal. 2016;30(5):590\u20136.","journal-title":"J Clin Lab Anal"},{"key":"9068_CR15","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1111\/j.1572-0241.2000.03207.x","volume":"95","author":"A Duchini","year":"2000","unstructured":"Duchini A, McHutchison JG, Pockros PJ. LKM-positive autoimmune hepatitis in the western United States: a case series. Am J Gastroenterol. 2000;95:3238\u201341.","journal-title":"Am J Gastroenterol"},{"issue":"43","key":"9068_CR16","first-page":"3","volume":"42\u201352","author":"GV Gregorio","year":"2015","unstructured":"Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Paedatic J Clin Transl Hepatol. 2015;42\u201352(43):3.","journal-title":"Paedatic J Clin Transl Hepatol"},{"key":"9068_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","volume":"21","author":"NK Gatselis","year":"2015","unstructured":"Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN. Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol. 2015;21:60\u201383.","journal-title":"World J Gastroenterol"},{"key":"9068_CR18","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.3748\/wjg.14.3374","volume":"14","author":"DP Bogdanos","year":"2008","unstructured":"Bogdanos DP, Invernizzi P, Mackay IR, Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol. 2008;14:3374\u201387.","journal-title":"World J Gastroenterol"},{"key":"9068_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/jcla.21813","volume":"30","author":"D Villata","year":"2016","unstructured":"Villata D, Girolami E, Alessio MG, et al. Autoantibody profiling in a cohort of pediatric and adult patients with autoimmune hepatitis. J Clin Lab Anal. 2016;30:41\u20136.","journal-title":"J Clin Lab Anal"},{"key":"9068_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/MEG.0000000000000870","volume":"29","author":"M Paolo","year":"2017","unstructured":"Paolo M, Cumali E, Luigi M, Ersan O Schiano T, Yoshida EM, Heurgu\u00e9-Berlot, et al. Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study. Eur J Gastroenterol Hepatol. 2017;29:777\u201380.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9068_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s13317-012-0041-4","volume":"3","author":"D Roggenbruck","year":"2012","unstructured":"Roggenbruck D, Mytilnaiou MG, Lapin SV, Rheinhold D, Conrad K. Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity. Autoimmun Highlights. 2012;3:119\u201325.","journal-title":"Autoimmun Highlights"},{"key":"9068_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/liv.12690","volume":"35","author":"GL Norman","year":"2015","unstructured":"Norman GL, Yang CY, Ostendorff HP, Lim MJ, Wang J, et al. Anti-Kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver Int. 2015;35:642\u201351.","journal-title":"Liver Int"},{"key":"9068_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1046\/j.1365-2249.2002.01754.x","volume":"127","author":"SD Lytton","year":"2012","unstructured":"Lytton SD, Berg U, Nemeth A, Ingelman-Sundberg M. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs. Clin Exp Immunol. 2012;127:293\u2013302.","journal-title":"Clin Exp Immunol"},{"key":"9068_CR24","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.jpeds.2013.05.042","volume":"163","author":"M Woynarowski","year":"2013","unstructured":"Woynarowski M, Nemeth A, Baruch Y. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. J Pediatr. 2013;163:1347\u201353.","journal-title":"J Pediatr"},{"key":"9068_CR25","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","volume":"19","author":"KP Batts","year":"1995","unstructured":"Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995;19:1409\u201317.","journal-title":"Am J Surg Pathol"},{"key":"9068_CR26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"GD Goodman","year":"2007","unstructured":"Goodman GD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47:598\u2013607.","journal-title":"J Hepatol"},{"key":"9068_CR27","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/hep.22261","volume":"47","author":"EA Roberts","year":"2008","unstructured":"Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson Disease: an update. Hepatology. 2008;47:2090\u2013111.","journal-title":"Hepatology"},{"key":"9068_CR28","doi-asserted-by":"publisher","first-page":"407.428","DOI":"10.1615\/CritRevImmunol.2017017868","volume":"36","author":"G Lauletta","year":"2016","unstructured":"Lauletta G, Russi S, Pavone F, Marzullo A, Tampoia A, Sansonno D, et al. Autoimmune hepatitis: factors involved in initiation and methods of diagnosis and treatment. Crit Rev Immunol. 2016;36:407.428.","journal-title":"Crit Rev Immunol"},{"key":"9068_CR29","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/ajg.2015.139","volume":"110","author":"HK Dhaliwal","year":"2015","unstructured":"Dhaliwal HK, Hoeroldt BS, Dube AK, McFarlane E, Underwood JC, Karajeh MA, et al. Long-term prognostic significance of persisting histological activity despite biochemical remission in autoimmune hepatitis. Am J Gastroenterol. 2015;110:993\u20139.","journal-title":"Am J Gastroenterol"},{"key":"9068_CR30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MEG.0000000000000545","volume":"28","author":"Y Aizawaa","year":"2016","unstructured":"Aizawaa Y, Abea H, Sugitaa T, Sekia N, Chuganjic Y, Furumotoc Y, et al. Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis. Eur J Gastroenterol Hepatol. 2016;28:391\u20137.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9068_CR31","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/MEG.0000000000000982","volume":"29","author":"A Abdel-Razik","year":"2017","unstructured":"Abdel-Razik A, Mousa N, Zakaria S, Elhelaly R, Elzehery R, Zalata K, et al. New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume. Eur J Gastroenterol Hepatol. 2017;29:1373\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9068_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41598-017-18818-5","volume":"8","author":"J Diestelhorst","year":"2018","unstructured":"Diestelhorst J, Junge N, Jonigk D, Schlue J, Falk CS, Manns MP, et al. Baseline IL-2 and the AIH score can predict the response to standard therapy in paediatric autoimmune hepatitis. Sci Rep. 2018;8:419.","journal-title":"Sci Rep"},{"key":"9068_CR33","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1021\/acs.jmedchem.5b00461","volume":"58","author":"AB Dounay","year":"2015","unstructured":"Dounay AB, Tuttle JB, Verhoest PR. Challenges and opportunities in the discovery of new therapeutics targeting the kynurenine pathway. J Med Chem. 2015;58:8762\u201382.","journal-title":"J Med Chem"},{"key":"9068_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/aje\/kwv242","volume":"183","author":"H Zuo","year":"2016","unstructured":"Zuo H, Ueland PM, Ulvik A, Eussen S, et al. Plasma biomarkers of inflammation, the kynurenine pathway, and risks of all-cause, cancer, and cardiovascular disease mortality: the Hordaland health study. Am J Epidemiol. 2016;183:249\u201358.","journal-title":"Am J Epidemiol"},{"key":"9068_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2016.07.004","volume":"75","author":"C Lippens","year":"2016","unstructured":"Lippens C, Duraes FV, Dubrot J, Brighouse D, Lacroix M, Irla M, et al. IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity. J Autoimmun. 2016;75:39\u201349.","journal-title":"J Autoimmun"},{"key":"9068_CR36","doi-asserted-by":"publisher","first-page":"e0130715","DOI":"10.1371\/journal.pone.0130715","volume":"10","author":"R Mancuso","year":"2015","unstructured":"Mancuso R, Hernis A, Agostini S, Rovaris M, Caputo D, Fuchs D, et al. Indoleamine 2,3 dioxygenase (IDO) expression and activity in relapsing-remitting multiple sclerosis. PlosOne. 2015;10:e0130715. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0130715\n                    \n                  .","journal-title":"PlosOne"},{"key":"9068_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/bjd.14779","volume":"176","author":"M Llamas-Velasco","year":"2017","unstructured":"Llamas-Velasco M, Bonay P, Jos\u00e9 Concha-Garz\u00f3n M, Corvo-Vill\u00e9n L, Cibri\u00e1n D, Sanguino-Pascual A, et al. Immune cells from patients with psoriasis are defective in inducing indoleamine 2,3-dioxygenase expression in response to inflammatory stimuli. Br J Dermatol. 2017;176:695\u2013704.","journal-title":"Br J Dermatol"},{"key":"9068_CR38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nrrheum.2014.96","volume":"10","author":"NJ Bernard","year":"2014","unstructured":"Bernard NJ. Rheumatoid arthritis: who knows why regulatory T cells are defective in RA. IDO Nat Rev Rheumatol. 2014;10:381\u201396.","journal-title":"IDO Nat Rev Rheumatol"},{"key":"9068_CR39","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/art.27403","volume":"62","author":"C Konstantia-Maria","year":"2010","unstructured":"Konstantia-Maria C, Shukla D, Keteepe-Arachi T, Sekel JA, Fuchs D, Pussey CD, et al. Regulation of myeloperoxidase-specific T cell responses during disease remission in anti-neutrophil cytoplasmic antibody\u2013associated vasculitis: the role of Treg cells and tryptophan degradation. Arthritis Rheum. 2010;62:1539\u201348.","journal-title":"Arthritis Rheum"},{"key":"9068_CR40","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3109\/02713683.2015.1133830","volume":"41","author":"SS Palabiyik","year":"2016","unstructured":"Palabiyik SS, Keles S, Girgin G, Arpali-Tanas E, Topdagi E, Baydar T. Neopterin release and tryptophan degradation in patients with uveitis. Curr Eye Res. 2016;41:1513\u20137.","journal-title":"Curr Eye Res"},{"key":"9068_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.12659\/AOT.889764","volume":"19","author":"J Kaden","year":"2014","unstructured":"Kaden J, Abendroth DE, V\u00f6lp M, Marzinzig M, Wesslau C. Causes and prognostic value of pre-transplant elevated kynurenine level in kidney allograft recipients. Ann Transplant. 2014;19:51\u20139.","journal-title":"Ann Transplant"},{"key":"9068_CR42","doi-asserted-by":"crossref","unstructured":"Kaden J, Abendroth D, V\u00f6lp A, Marzinzig M. Dynamics and diagnostic relevance of kynurenine serum level after kidney transplantation. Ann Transpl. 2015;20:327\u201337.","DOI":"10.12659\/AOT.893721"},{"key":"9068_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/hep.28282","volume":"63","author":"S Yoshio","year":"2016","unstructured":"Yoshio S, Sugiyama M, Shoji H, et al. Indoleamine-2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B. Hepatol. 2016;63:3\u201394.","journal-title":"Hepatol"},{"key":"9068_CR44","doi-asserted-by":"publisher","first-page":"e78146","DOI":"10.1371\/journal.pone.0078146","volume":"8","author":"MA Jenabian","year":"2013","unstructured":"Jenabian MA, Patel M, Kema I, Kanagaratham C, Radzioch D, Th\u00e9bault P, et al. Distinct tryptophan catabolism and Th17\/Treg balance in HIV progressors and elite controllers. PLoS One. 2013;8:e78146. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0078146\n                    \n                  .","journal-title":"PLoS One"},{"key":"9068_CR45","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12879-015-1087-5","volume":"15","author":"P Bipath","year":"2015","unstructured":"Bipath P, Levay PF, Viljoen M. The kynurenine pathway activities in a sub-Saharan HIV\/AIDS population. BMC Infect Dis. 2015;15:346\u201361.","journal-title":"BMC Infect Dis"},{"key":"9068_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4137\/IJTR.S26862","volume":"8","author":"J Mehraj","year":"2015","unstructured":"Mehraj J, Routy JP. Tryptophan catabolism in chronic viral infections: handling uninvited guests. Int J Tryptophan Res. 2015;8:41\u20136.","journal-title":"Int J Tryptophan Res"},{"key":"9068_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/ph8020337","volume":"8","author":"H Zoller","year":"2015","unstructured":"Zoller H, Jenal A, Staettermayer AF, Schroecksnadel S, Ferenci P, Fuchs D. Tryptophan breakdown in patients with HCV infection is influenced by IL28B polymorphism. Pharmaceuticals. 2015;8:337\u201350.","journal-title":"Pharmaceuticals"},{"key":"9068_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","volume":"14","author":"KM Danikowski","year":"2017","unstructured":"Danikowski KM, Jayaraman S, Prabhaka BS. Regulatory T cells in multiple sclerosis and myasthenia gravis. J Neuroinflammation. 2017;14:117\u201333.","journal-title":"J Neuroinflammation"},{"key":"9068_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1515\/pterid-2014-0015","volume":"26","author":"S Geisler","year":"2015","unstructured":"Geisler S, Mayersbach P, Becker K, Schennach H, Fuchs D, Gostner JM. Serum tryptophan, kynurenine, phenylalanine, tyrosine and neopterin concentrations in 100 healthy blood donors. Pteridines. 2015;26:31\u20136.","journal-title":"Pteridines"},{"key":"9068_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cca.2005.06.013","volume":"364","author":"K Schr\u00f6cksnadel","year":"2016","unstructured":"Schr\u00f6cksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta. 2016;364:82\u201390.","journal-title":"Clin Chim Acta"},{"key":"9068_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1440-1746.1991.tb01147.x","volume":"6","author":"RN Gibson","year":"1991","unstructured":"Gibson RN, Donlan JD, Ditchfield MR, Bhathal PS. Duplex Doppler ultrasound of the ligamentum teres and portal vein: a clinically useful adjunct in the evaluation of patients with known or suspected chronic liver disease or portal hypertension. J Gastroenterol Hepatol. 1991;6:61\u20135.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-019-9068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-019-9068-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-019-9068-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T19:11:05Z","timestamp":1579547465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-019-9068-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,21]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["9068"],"URL":"https:\/\/doi.org\/10.1007\/s12026-019-9068-1","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,21]]},"assertion":[{"value":"21 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by Ethics Committee of the Children\u2019s Memorial Health Institute no 192\/KBE\/2015 and 231\/KBE\/2015.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}